324 institutions reported holding $2.96B of GENMAB (GMAB) in SEC 13F filings for 2026-06-30. Largest institutional holders: Paradigm Biocapital Advisors LP ($360.8M), Orbis Allan Gray Ltd ($312.3M), Deep Track Capital, LP ($237.6M), ALLIANCEBERNSTEIN L.P. ($231.9M), DEERFIELD MANAGEMENT COMPANY, L.P. ($188.6M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30